… therapeutic peptide — for the treatment of patients with pancreatic … Dr. Hatem Azim, chief medical officer of PEP-Therapy, … ongoing trial is 53 patients. "Receiving FDA’s [orphan drug designation … PEP-Therapy concludes by stating that the Company will …

… (tecentriq) with rituximab (Rituxan), gemcitabine (gemzar), and oxaliplatin (eloxatin; GemOx; R … RT. The multicenter phase 1 trial included centers at Emory University …

… cancer, treatment of IMM-1-104 in combination with modified Gemzar plus … to expand the phase 2a trial to include three additional … Chair and Section Chief for Medical Oncology in the Department of … three phase 2a pancreatic cancer trial groups. Of the seven …

… organization (CDMO) agreement with Lotus Pharmaceutical, a Taiwanese oncology specialist, for … and producing strategic original essential medicines for overseas markets, Boryung aims … domestic rights to the anticancer drug Gemzar (gemcitabine) in 2020, the …

… ongoing phase 1/2 trial show promising anti-tumor activity … , the FDA granted orphan drug designation to elraglusib for the treatment of individuals … focusing on elraglusib plus gemcitabine (Gemzar; Eli Lilly) and nab-paclitaxel …

… Processa Pharmaceuticals. “Our NGC-Cap Phase 2 clinical trial in … S. Food and Drug Administration (FDA)-approved drugs to extend cancer … clinical trial (NCT06568692) evaluating NGC-Cap for the treatment of … oral analog of gemcitabine (Gemzar®) that is converted …

… Officer of Processa Pharmaceuticals. “Upon receiving FDA clearance of our … New Drug application (IND) application for a Phase 2 trial with … or fail all other treatments. NGC-Cap demonstrated greater … oral analog of gemcitabine (Gemzar®) that is converted to …

… s Phase III trial evaluating a drug-device combination … at the University of Nebraska Medical Center (UNMC) – joins … Gemzar with another chemotherapy drug Abraxane (nab paclitaxel). The treatment … cancer candidates in clinical trials as companies aim to …

… relies on the drug Tasigna, among other treatments. This medication is essential for … medications such as fulvestrant, gemzar, and paclitaxel. These drugs are vital for their treatment … -life-represented-the-case-in-trial-2124509; https://www …

… translocation RCC, highlighting that treatment with a combination of … adding bevacizumab [to gemcitabine (Gemzar) plus platinum-based chemotherapy] … 2 different classes of drugs,” she added. There … -304 trial (NCT05678673).1 “Although we have pending trials, I …